Table 5 Pathological diagnosis of NDRD
From: Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach
Type of NDRD | All (n = 40) | Isolated NDRD (n = 26) | NDRD + DN (n = 14) | Pvalue |
|---|---|---|---|---|
Membranous nephropathy | 14 (35%) | 11 (42.3%) | 3 (21.4%) | 0.187 |
Focal segmental glomerulosclerosis | 5 (12.5%) | 4 (15.4%) | 1 (7.1%) | 0.452 |
Crescentic glomerulonephritis | 5 (12.5%) | 1 (3.8%) | 4 (28.6%) | 0.024 |
IgA nephropathy | 3 (7.5%) | 0 | 3 (21.4%) | 0.014 |
Chronic tubulointerstitial nephritis | 3 (7.5%) | 3 (11.5%) | 0 | 0.186 |
Minimal change disease | 2 (5%) | 2 (7.7%) | 0 | 0.287 |
Lupus nephritis | 2 (5%) | 1 (3.8%) | 1 (7.1%) | 0.648 |
Amyloidosis | 1 (2.5%) | 1 (3.8%) | 0 | 0.457 |
Cryoglobulinemic glomerulonephritis | 1 (2.5%) | 1 (3.8%) | 0 | 0.457 |
Fibrillary glomerulonephritis | 1 (2.5%) | 0 | 1 (7.1%) | 0.168 |
Poststreptococcal glomerulonephritis | 1 (2.5%) | 0 | 1 (7.1%) | 0.168 |
Hypertensive nephropathy | 1 (2.5%) | 1 (3.8%) | 0 | 0.457 |
Acute interstitial nephritis | 1 (2.5%) | 1 (3.8%) | 0 | 0.457 |